Form 10-Q Carisma Therapeutics For: Mar 31
http://archive.fast-edgar.com/20240509/A3LZT22CZ22GS2W2222T22Z2CS3DZZ226Q62
Filed on: May 9, 2024
Form 8-K MARCUS CORP For: May 08
http://archive.fast-edgar.com/20240509/AU229222Z22222Z2222P22OCNMKMFV222262
Filed on: May 9, 2024
Form 8-K ROYAL GOLD INC For: May 08
FALSE000008553500000855352024-05-082024-05-08UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-KCURRENT REPORTPursuant to Section 13 or 15(d) ofthe Securities Exchange Act of 1934Date of Report (Date of earliest event reported): May 8, 2024 Royal Gold, Inc.(Exact name of registrant as specified in its charter)Delaware001-1335784-0835164(State or other jurisdictionof incorporation)(CommissionFile Number)(IRS EmployerIdentification No.)1144 15th... (continue reading...)
Form 4 CITIZENS FINANCIAL SERVI For: May 09 Filed by: LANDY R JOSEPH
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 10-Q PALTALK, INC. For: Mar 31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2024
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ________ to ________
Commission File Number 001-38717
PALTALK, INC.
(Exact name of... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K GoHealth, Inc. For: May 09
-
Form 6-K Kingsoft Cloud Holdings For: May 09
-
Form 8-K Cars.com Inc. For: May 09
-
Form 10-Q Monte Rosa Therapeutics, For: Mar 31
-
Form DEFA14A MERRIMACK PHARMACEUTICAL
-
Form 8-K XOMA Corp For: May 09
-
Form 8-K PALTALK, INC. For: May 09
-
Form SC 13D/A Apyx Medical Corp Filed by: Vizirgianakis Stavros G.
-
Form 8-K Enfusion, Inc. For: May 09
-
Form 8-K Viatris Inc For: May 09
-
Form 8-K Priority Technology Hold For: May 09
-
Form 8-K MERRIMACK PHARMACEUTICAL For: May 08
-
Form 10-Q Whole Earth Brands, Inc. For: Mar 31
-
Form 8-K Carisma Therapeutics For: May 09
-
Form 8-K Krispy Kreme, Inc. For: May 09
-
Form 8-K CorMedix Inc. For: May 09
-
Form 8-K Intellia Therapeutics, For: May 09
-
Form 8-K SelectQuote, Inc. For: May 09
-
Form 8-K Hilton Grand Vacations For: May 09
-
Form 8-K Whole Earth Brands, Inc. For: May 09
-
Form 8-K Wave Life Sciences Ltd. For: May 09
-
Form 8-K NETSCOUT SYSTEMS INC For: May 09
-
Form 8-K Sensei Biotherapeutics, For: May 09
-
Form 8-K KELLY SERVICES INC For: May 09
-
Form 6-K Nano Labs Ltd For: May 09
-
Form 10-Q XOMA Corp For: Mar 31
-
Form 8-K INGLES MARKETS INC For: May 09
-
Form 8-K QUALCOMM INC/DE For: May 09
-
Form 8-K Century Therapeutics, For: May 09
-
Form 10-Q iHeartMedia, Inc. For: Mar 31
-
Form 8-K Installed Building Produ For: May 09
-
Form 10-Q Cronos Group Inc. For: Mar 31
-
Form 8-K iHeartMedia, Inc. For: May 09
-
Form 8-K Cronos Group Inc. For: May 09
-
Form 8-K ESSENTIAL PROPERTIES For: May 09
-
Form 8-K CHARLES RIVER LABORATORI For: May 09
-
Form 10-Q Century Therapeutics, For: Mar 31
-
Form 10-Q Vital Farms, Inc. For: Mar 31
-
Form 8-K PAR TECHNOLOGY CORP For: May 09
-
Form 8-K TILE SHOP HOLDINGS, INC. For: May 09
-
Form 8-K Vera Therapeutics, Inc. For: May 09
-
Form 8-K Coherus BioSciences, For: May 08
-
Form 6-K NOVA LTD. For: May 09
-
Form 6-K Ferrovial SE For: May 09
-
Form 8-K LENSAR, Inc. For: May 09
-
Form 8-K Cheniere Energy, Inc. For: May 08
-
Form 10-Q TRENDMAKER INC. LTD. For: Mar 31
-
Form 6-K Canadian Solar Inc. For: May 09
-
Form S-3 LanzaTech Global, Inc.
-
Form 424B3 Q32 Bio Inc.
